Preclinical Imaging Market Future Trends, Industry Size and Forecast to 2032

 The global preclinical imaging market size projected to reach a valuation of US$ 3.3 billion in 2022 and to grow at a CAGR of 3.5% to US$ 4.7 billion by the end of 2032.

Preclinical Imaging is used for imagianing of living animals specifically for research purposes, research can be for drug development and other types. Imaging products are very important so as to observe the changes in organs, cell or a tissue these changes are observed in animals that respond to environmental changes or physiological changes. Imaging modalities are mostly non-invasive and in vivo and are considered to be important for studying animal.

There are different types of modalities which are used for preclinical imaging such as CT imaging, MRI imaging, PET/SPECT imaging, multimodal imaging, optical imaging, ultrasound imaging, and photoacoustic (PAT) imaging.

Apart from above factors preclinical imaging market has huge growth potential and is expected to continue over the forecast period. Technological advancement in preclinical imaging and the increasing adoption of molecular imaging technology for drug development tool are some factors that are expected to drive the preclinical imaging market over the forecast period.

Moreover, companies are into collaborations with the biotechnology and pharmaceutical companies to increase its geographical footprint globally which is expected to drive the global preclinical imaging market over the forecast period.

Preclinical Imaging Market: Drivers and Restraints

The demand for preclinical imaging market is fueled by technical innovation and discretionary funding which is thereby expected to drive the demand for preclinical imaging market over the forecast period. In addition the increasing number of clinical research organizations (CROs), research and development institutes, biotechnology and pharmaceuticals companies and other end users are propelling demand for preclinical imaging products.

Encouragement for research and development, huge investments by government for research and need for drug development is expected to witness robust market growth during the forecast period. Moreover increasing applications such as life sciences, cosmetic industry and others for preclinical products is another factor that is expected to drive growth of the global preclinical imaging market over the forecast period.

However, high cost of preclinical imaging systems and lack of awareness regarding preclinical imaging technology is expected to impede revenue growth of the preclinical imaging market over the forecast period.

Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-2816

Preclinical Imaging Market: Regional Overview

Geographically, the global Preclinical Imaging Market, is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan, Middle East and Africa (MEA).

North America dominates the global preclinical imaging market followed by Europe. North America and Western Europe regions are expected to witness robust growth due to increase in research and development and with the number of developed research infrastructure is expected to fuel the revenue growth in these regions. APEJ is expected to witness significant growth as compared to other regions and countries owing to government programs for preclinical imaging and funding for research and development expected to fuel market growth in this region. Moreover, rapidly expanding contract research organization in this region is expected to have a significant impact on the market growth.  However, increasing research and educational institutes may boost the growth of preclinical imaging market in these regions during the forecast period.

Preclinical Imaging Market: Key Players

Pre-clinical imaging system companies are Bruker Corporation, Thermo Fisher Scientific, General Electric, PerkinElmer, Inc., VisualSonics, Inc., MILabs B.V., Siemens A.G., TriFoil Imaging, Mediso Ltd., and Agilent Technologies and others.

Preclinical Imaging Market: Segmentation

The global preclinical imaging market, is segmented on the basis of product type, by application, by end user and region.

Segmentation by Product Type

  • Medical Devices
  • CT Imaging
  • MRI Imaging
  • PET/SPECT Imaging
  • Multimodal Imaging
  • Optical Imaging
  • Ultrasound Imaging
  • Photoacoustic (PAT) Imaging
  • Reagents
  • Services

Segmentation by Applications

  • Oncology
  • Neurology
  • Cardiology
  • Inflammation
  • Infectious diseases

Segmentation by End User

  • Hospitals
  • Clinics
  • Research Institutes

Comments

Post a Comment

Popular posts from this blog

Dental Burs Market | Growth Opportunities, Business Insights And Forecast To 2032

With an anticipated market value of over  US$ 139.2 Million as of 2022 , the demand for  dental burs market size   is expected to experience a significant CAGR growth value of about  7.8%  from 2022 to 2032, reaching an estimated market value of  US$ 295.6 Million in 2032.  Specialty clinics will account for a significant 40.1% of the end-user sector of the global market in 2021, according to forecasts from Future Market Insights. Over the last two decades, the frequency of dental disorders such as gum disease, dental crack, periodontal disease, and dental cavities has been on the rise. This is expected to boost the worldwide dental burs market. Dentin removal, cutting hard tissues, implantology, cavity preparation and other procedures need the use of dental burs, which are frequently made of stainless steel, tungsten carbide, and diamond grit. The most common and preventable dental condition is dental caries. This factor is associated with changing lifestyles as well as individual eat
Read more

Commercial Helicopter Market Key Players, SWOT Analysis, Key Indicators & Forecast By 2032

  The global   commercial helicopter market size  is expected to reach a valuation of US$ 11.5 Bn by 2032, with the market expanding at a positive CAGR of 6.4% from 2022 to 2032. Valued at US$ 5.9 Bn in 2021, the target market is expected to reach an estimated US$ 6.2 Bn in 2022. Key Takeaways: The commercial helicopter market in the United States will grow at 5.5% CAGR, reaching US$ 3.9 Bn by 2032. In Europe, the commercial helicopter market is predicted to expand at a CAGR of 6%, arriving at a value of US$ 2.8 Bn during the assessment period. By type, the light commercial helicopter segment is anticipated to register a CAGR of 6% during 2022-2032. Based on application, the public safety and law enforcement segment is leading the market with a CAGR of 5.5% during the forecast period. The elevated need for  commercial helicopters  in emergency services, VIP transport, military and defense activities, and oil and gas rigs as well as the replacement of older fleets propel the growth of t
Read more

Body Contouring Market To Undertake Strapping Growth By The End 2032 | FMI

  The  body contouring market size  is anticipated to grow at a  CAGR of 6.9%  from 2022 to 2032, rising from  US$ 7.3 billion in 2022  to  US$ 11.1 billion  in valuation by  2032 . The team of analysts at Future Market Insights are focusing on research and market study to produce different Body Contouring Market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Body Contouring Market. Top Market Players : Key players operating in the body contouring market are – GlobalMed Technologies Chromogenex, Human Med. Wells Johnson Company Invasix Aesthetic Solutions Erchonia Fotona Cutera BTL Industries Meridian Palomar Medical Technologies Others Key Market Segmentation Covered in the Study : By Invasiveness: Non-Invasive Contouring Minimally Invasive Contouring Invasive Contouring By End-user:
Read more